Turnover
≈ €190,000 estimated
The accounts state no turnover.
SYNAMED
Lifetime
2 annual accounts with figures on one time axispeak €107,745 (2025)
€107,745▲ 97.5%
lowest -€5,236 (2024)
€29,265▲ €34,501
peak €29,029 (2025)
€29,029▲ €29,265
€8,500▼ 59.4%
Board1 name since 2024
1 director
Documentsfilings and deeds
30-08-202630 days late
2025abbreviated format
Gross margin from €54,549 to €107,745Back to profit: €29,265Equity from -€236 to €29,029Debts from €20,940 to €8,500Cash from €7,596 to €35,015
Key points
from the 2025 annual accountsLiquidity
4.34 was 0.94 in 2024
Short-term debts fell from €20,940 to €8,500.
Position in the sector
€29,029
Less equity than 87% of companies in human health. Sector median €438,449 · 2,809 companies.
2025 accounts filed 30 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as SYNAMED has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for SYNAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1006481995
Incorporation
Founding capital of €5,000, 100 shares · Founder: (comparant requérant les statuts) · Appointment: (director) · published on 29-02-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SYNAMED Schaerbeek | €37,529 | €107,745 | 77.4% | - |
| DOCTEUR HECHTERMANS Etterbeek | €53,050 | €88,692 | 74.8% | - |
| ArtsenAssociatie de Lijster Aalbeke Kortrijk | €31,554 | €75,703 | 31.7% | - |
| MAISON MEDICALE PADUWA Evere | €50,803 | €116,266 | -148.5% | - |
| Dr. Boon Isabelle Bornem | €44,617 | €120,858 | 11.2% | - |
| ALANBUQY MEDICAL Lennik | €60,566 | €83,450 | 45.4% | - |
| Dr. Annelies Hiele Tienen | €42,817 | €76,837 | 4.7% | - |
These companies have the same main activity as SYNAMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €31,600 and €60,600, founded between 2021 and 2024.
Official details
Source: KBO- Status
- Active since 27-02-2024Normal situation
- Activity
- General medical practiceNACE 86210
- Financial year end
- 31 December
- Peppol
- Reachable since 07-01-2026
Insights on SYNAMED
SYNAMED has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,029 and a net result of €29,265.
Its solvency ranks better than 68% of 2,809 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SYNAMED
- What is the company number of SYNAMED?
- The company number of SYNAMED is 1006.481.995. The VAT number is the same number with BE in front: BE 1006.481.995.
- Where is SYNAMED based?
- The registered office is at Louis Bertrandlaan 60, 1030 Schaerbeek.Company details
- What does SYNAMED do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of SYNAMED?
- SYNAMED is a private limited company (BV).
- When was SYNAMED founded?
- SYNAMED was founded on 27-02-2024.
- Is SYNAMED still active?
- Yes, SYNAMED is an active enterprise in the KBO register.
- What is the turnover of SYNAMED?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €107,745 and 30 comparable companies (NACE 86210). It probably lies between €160,000 and €240,000.Financials
- Is SYNAMED profitable?
- In financial year 2025, SYNAMED made a profit of €29,265.
- Where can I find the annual accounts of SYNAMED?
- SYNAMED filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SYNAMED due?
- SYNAMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.